GO:0060351 cartilage development involved in endochondral bone morphogenesis: Process, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0060351 describes the cartilage-specific developmental process that builds the transient scaffold for endochondral bone formation.
• Endochondral ossification is the dominant route for long bone, vertebral, and appendicular skeleton formation in vertebrates [1,6].
• The process is driven by sequential chondrocyte proliferation, hypertrophy, matrix remodeling, and vascular invasion [1,2].
• RUNX2, SOX9, and Indian hedgehog (IHH) are central transcriptional and signaling regulators of this cartilage program [7,8].
• Disruption of GO:0060351 contributes to skeletal dysplasias, metabolic bone disease, and impaired fracture healing [3,5].
• CRISPR knockout, knock-in, and overexpression models enable causal dissection of genes acting in this process [2,4].
Description
GO:0060351, cartilage development involved in endochondral bone morphogenesis, is a biological process term that captures the formation and maturation of the cartilage template that is later replaced by bone. Endochondral ossification is the principal mechanism by which most of the vertebrate skeleton, including long bones, vertebrae, and the appendicular skeleton, is formed [1,6]. The cartilage intermediate is not a passive placeholder; it is a highly organized, dynamically remodeled tissue whose cells and matrix instruct the subsequent mineralization front [1,2]. Understanding this process is therefore central to developmental biology, skeletal genetics, and regenerative medicine [2,3]. The term is defined in QuickGO as the process whose specific outcome is the progression of the cartilage that will provide a scaffold for mineralization of endochondral bones. This definition places the emphasis on the cartilage progression itself, rather than on the later ossification steps, making GO:0060351 a precise annotation target for genes that act before and during cartilage template maturation. Researchers annotate genes to GO:0060351 when loss- or gain-of-function experiments show a specific defect in the cartilage scaffold, such as altered chondrocyte proliferation, delayed hypertrophy, or abnormal matrix deposition [7,8]. Because the process is conserved across mammals, findings in murine models frequently translate to human skeletal biology [1,2].
cartilage development involved in endochondral bone morphogenesis At A Glance
| GO ID | GO:0060351 |
|---|---|
| GO term | cartilage development involved in endochondral bone morphogenesis |
| Ontology | biological_process |
| Synonym | None listed in QuickGO |
| Major function | Progression of the cartilage template that provides a scaffold for endochondral bone mineralization |
| Related process | Endochondral ossification |
| Key cell type | Chondrocyte |
| Key tissue | Transient cartilage anlage / growth plate cartilage |
What Is GO:0060351?
In our own words, GO:0060351 refers to the developmental program in which a cartilage anlage is established, expanded, and matured so that it can serve as the scaffold for endochondral bone mineralization. It covers the progression of that cartilage, including the behavior of chondrocytes and the extracellular matrix they produce, but it is specifically tied to the cartilage that will be replaced by endochondral bone rather than to permanent articular cartilage or to intramembranous bone formation.
Why Is cartilage development involved in endochondral bone morphogenesis Important in Cell Biology?
GO:0060351 is important because endochondral ossification is the dominant mechanism of vertebrate skeletal formation, and defects in the underlying cartilage program cause a broad spectrum of human skeletal and metabolic disorders [1,5]. Because the cartilage template determines bone length, shape, and mechanical competence, genes acting in this process are high-value targets for understanding growth disorders, fracture repair, and skeletal regeneration [2,3].
• Endochondral ossification generates most of the axial and appendicular skeleton [1,6].
• The cartilage template sets bone length and shape, so its disruption causes skeletal dysplasia.
• Chondrocyte hypertrophy and matrix remodeling are required for vascular invasion and marrow formation [1,2].
• Impaired cartilage progression contributes to delayed fracture healing, especially with aging and endocrine disease.
• Metabolic disorders such as mucopolysaccharidoses and related conditions perturb cartilage and bone remodeling.
• Skeletal stem and progenitor cells that support cartilage and bone repair are active research targets.
• Craniofacial endochondral bone formation, including Meckel's cartilage, depends on this program.
• Pediatric imaging of the immature appendicular skeleton reflects the underlying cartilage template.
• RUNX2-dependent transcriptional control is a central node in this process.
• Bone and cartilage differentiation studies provide the conceptual framework for the term.
What Happens During cartilage development involved in endochondral bone morphogenesis?
Mesenchymal condensation and chondrogenic commitment
In simple terms: First, loose mesenchyme cells gather and decide to become cartilage cells.
The process begins with condensation of mesenchymal progenitors at future skeletal sites, followed by commitment to the chondrogenic lineage [1,2]. Skeletal stem and progenitor cells within these condensations give rise to chondrocytes that will build the cartilage template. This step establishes the cartilaginous anlage that is the substrate for all subsequent endochondral events.
Chondrocyte proliferation and matrix deposition
In simple terms: Cartilage cells multiply and secrete the matrix that gives the template its shape.
Committed chondrocytes proliferate and deposit a characteristic extracellular matrix rich in collagen and proteoglycans, expanding the cartilage template [1,7]. This proliferative phase determines the initial size of the skeletal element and is tightly linked to subsequent growth plate organization [1,6]. Matrix composition at this stage is critical for the mechanical and signaling properties of the template.
Chondrocyte hypertrophy and maturation
In simple terms: Cartilage cells enlarge and change their behavior to prepare the template for bone.
Proliferating chondrocytes transition into hypertrophic chondrocytes, which enlarge, alter matrix production, and secrete factors that recruit vascular and skeletal progenitors [1,2]. Hypertrophy is a hallmark of the cartilage progression captured by GO:0060351 and is required for the template to become competent for mineralization. Disruption of this transition impairs endochondral bone formation.
Matrix remodeling and vascular invasion
In simple terms: The cartilage matrix is broken down and blood vessels move in, bringing bone-forming cells.
Terminal hypertrophic chondrocytes remodel the surrounding matrix and attract vascular invasion, which delivers osteoprogenitors and hematopoietic precursors [1,2]. This step couples cartilage progression to the onset of bone formation and marrow cavity development. Paracrine signaling between cartilage and osteogenic regions is essential for coordinating these events.
Transition to endochondral bone mineralization
In simple terms: Finally, the cartilage scaffold is mineralized and replaced by bone.
The remodeled cartilage template becomes the site of mineralization and is progressively replaced by bone tissue [1,7]. This transition is the specific outcome that defines GO:0060351, distinguishing it from earlier chondrogenic steps and from intramembranous ossification. Proper progression of the cartilage program is a prerequisite for normal bone architecture.
Key Genes Involved in GO:0060351 cartilage development involved in endochondral bone morphogenesis
The following genes and proteins are established regulators or markers of the cartilage program captured by GO:0060351, based on the cited literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| SOX9 | Master chondrogenic transcription factor | Required for chondrocyte commitment and cartilage template formation |
| RUNX2 | Transcriptional regulator of osteoblast and chondrocyte maturation | Central node in endochondral bone development |
| IHH | Indian hedgehog signaling ligand | Coordinates chondrocyte proliferation and hypertrophy |
| PTHLH | Parathyroid hormone-like hormone | Regulates the proliferation-to-hypertrophy transition |
| COL2A1 | Major cartilage collagen | Marker of proliferating chondrocytes and matrix integrity |
| COL10A1 | Hypertrophic chondrocyte collagen | Marker of chondrocyte hypertrophy |
| ACAN | Aggrecan proteoglycan | Major cartilage matrix component |
| MMP13 | Matrix metalloproteinase | Remodels hypertrophic cartilage matrix |
| VEGFA | Vascular endothelial growth factor A | Promotes vascular invasion of the cartilage template |
| FGFR3 | Fibroblast growth factor receptor 3 | Regulates chondrocyte proliferation |
| BMP2 | Bone morphogenetic protein 2 | Promotes chondrogenesis and osteogenesis |
| BMP4 | Bone morphogenetic protein 4 | Supports skeletal progenitor differentiation |
| WNT5A | Non-canonical Wnt ligand | Modulates chondrocyte differentiation |
| CTNNB1 | Beta-catenin | Canonical Wnt effector in skeletal development |
| SP7 | Osterix transcription factor | Osteoblast differentiation downstream of cartilage template |
| SOST | Sclerostin | Regulates bone formation in remodeling |
| ALPL | Alkaline phosphatase | Marker of mineralization |
How Is cartilage development involved in endochondral bone morphogenesis Regulated?
The cartilage program in GO:0060351 is regulated by a network of transcription factors and secreted signals. RUNX2 acts as a key transcriptional regulator of chondrocyte and osteoblast maturation during endochondral bone development. Indian hedgehog and parathyroid hormone-like hormone form a feedback loop that controls the rate of chondrocyte proliferation and the onset of hypertrophy. Bone morphogenetic proteins and Wnt ligands further modulate chondrogenic commitment and differentiation. Skeletal stem and progenitor cells provide a cellular reservoir that responds to these signals during development and repair.
cartilage development involved in endochondral bone morphogenesis and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| RUNX2 | Skeletal dysplasia / cleidocranial dysplasia | Knockout and point-mutation models in chondrogenic cells |
| SOX9 | Chondrodysplasia / campomelic dysplasia | Knockout and knock-in reporter models |
| COL2A1 | Type II collagenopathies | Point-mutation knock-in models |
| COL10A1 | Metaphyseal chondrodysplasia | Knockout and overexpression models |
| MMP13 | Matrix remodeling defects | Knockout models for cartilage remodeling |
Skeletal dysplasias and growth disorders
Disruption of genes acting in GO:0060351 causes skeletal dysplasias characterized by abnormal bone length, shape, or density. Because the cartilage template determines the size and architecture of endochondral bones, mutations that impair chondrocyte proliferation, hypertrophy, or matrix production manifest as growth defects [1,8]. RUNX2-dependent transcriptional programs are particularly important in this context.
Metabolic bone disease and remodeling disorders
Metabolic disorders can perturb bone development and remodeling, including the cartilage-dependent steps of endochondral ossification. Conditions that alter systemic metabolism or matrix turnover affect the cartilage template and its replacement by bone. This links GO:0060351 to clinical phenotypes beyond classical skeletal dysplasia.
Fracture healing, aging, and endocrine disease
Fracture healing recapitulates aspects of endochondral bone formation, including cartilage template formation. Endocrine diseases, aging, and cellular senescence impair this process and delay healing. Therefore, genes in GO:0060351 are relevant to regenerative failure in older or metabolically compromised patients.
Craniofacial and mandibular development
Endochondral bone formation in the craniofacial skeleton, including regions associated with Meckel's cartilage, depends on cartilage progression and paracrine signaling. An atlas of early human mandibular endochondral and osteogenic paracrine signaling regions highlights the importance of these interactions. Defects in this program can contribute to craniofacial anomalies.
From cartilage development involved in endochondral bone morphogenesis-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is a candidate gene required for cartilage template formation? | CRISPR knockout in chondrogenic cells or mouse |
| Does a specific variant alter chondrocyte differentiation? | Point-mutation knock-in |
| Where and when is a gene expressed during endochondral ossification? | Tagged knock-in reporter |
| Does increased gene dosage alter cartilage progression? | Overexpression model |
| Which signaling pathways act downstream of a candidate gene? | Knockout combined with transcriptomics |
| Can a gene rescue a cartilage defect? | Knock-in or overexpression rescue |
How to Study the cartilage development involved in endochondral bone morphogenesis Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Transcript abundance | Stage-specific gene expression in cartilage |
| Histology | Tissue and cell morphology | Phenotyping cartilage template defects |
| Immunohistochemistry | Protein localization | Marker expression in chondrocyte zones |
| Proteomics | Matrix and cellular protein composition | Cartilage matrix remodeling |
| Lineage tracing | Cell fate and origin | Chondrocyte contribution to bone |
| Reporter assays | Pathway activity | Signaling dynamics during endochondral ossification |
| Micro-CT | Bone architecture | Skeletal phenotyping |
| CRISPR screening | Gene function at scale | Discovery of regulators of cartilage progression |
Transcriptomic profiling of cartilage progression
RNA sequencing of microdissected cartilage zones or sorted chondrocyte populations can identify genes whose expression changes during the progression captured by GO:0060351. This approach is useful for defining stage-specific markers and for comparing wild-type and mutant templates.
Histology and imaging of the cartilage template
Histological staining and imaging of the immature skeleton reveal the organization of proliferating and hypertrophic chondrocytes and the extent of matrix deposition. These methods are essential for phenotyping models of GO:0060351 disruption.
Proteomic and matrix analysis
Proteomic analysis of cartilage matrix can identify compositional changes that affect template competence for mineralization. Such analyses complement transcriptomic data by capturing post-transcriptional and matrix-level regulation.
Lineage tracing and reporter assays
Genetic lineage tracing and reporter alleles allow researchers to follow chondrocyte descendants and to monitor pathway activity during endochondral bone formation. These tools are particularly valuable for linking candidate genes to specific steps of GO:0060351.
How CRISPR Can Be Used to Study GO:0060351 cartilage development involved in endochondral bone morphogenesis
Knockout
CRISPR knockout of candidate genes in chondrogenic cells or animal models can test whether a gene is required for the cartilage progression described by GO:0060351. Loss-of-function phenotypes such as delayed hypertrophy or matrix defects provide direct causal evidence for annotation.
Point Mutation
Point-mutation knock-in models allow researchers to test specific variants found in patients with skeletal disorders for their effects on chondrocyte differentiation and cartilage template formation. This approach distinguishes pathogenic variants from benign polymorphisms.
Knock-in
Knock-in of reporters or tags can reveal the spatial and temporal expression of genes during endochondral bone morphogenesis. Tagged alleles also enable biochemical isolation of protein complexes from cartilage tissue.
Overexpression
Overexpression models test whether increased dosage of a gene alters cartilage progression, matrix deposition, or the timing of hypertrophy. Such models are useful for studying gain-of-function mechanisms in skeletal disease.
How EDITGENE Supports cartilage development involved in endochondral bone morphogenesis Research
Researchers studying cartilage development involved in endochondral bone morphogenesis-related genes often need to determine whether a candidate gene is causally involved in the progression of the cartilage template, and to define the precise step at which it acts. EDITGENE provides the CRISPR and bioinformatics tools required to move from correlation to causation in this skeletal developmental process.
Contact EDITGENE today to design your custom CRISPR model for cartilage development involved in endochondral bone morphogenesis research.
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| TRPV4 Overexpression HEK293 Stable Cell Line | EDJ-GQ77 | Human | 59341 | Details Get a Quote |
| GHR Knockout HEK293 Cell Line | EDJ-KQ466 | Human | 2690 | Details Get a Quote |
| TRPV4 Knockout HEK293 Cell Line | EDJ-KQ1035 | Human | 59341 | Details Get a Quote |
| HOXA11 Knockout HEK293 Cell Line | EDJ-KQ2931 | Human | 3207 | Details Get a Quote |
| HOXA11 Knockout A-549 Cell Line | EDJ-KQ24042 | Human | 3207 | Details Get a Quote |
| HOXA11 Knockout HCT 116 Cell Line | EDJ-KQ24043 | Human | 3207 | Details Get a Quote |
| HOXA11 Knockout HeLa Cell Line | EDJ-KQ22674 | Human | 3207 | Details Get a Quote |
| GHR Knockout HeLa Cell Line | EDJ-KQ53337 | Human | 2690 | Details Get a Quote |
| TRPV4 Knockout HeLa Cell Line | EDJ-KQ56968 | Human | 59341 | Details Get a Quote |
| GHR Knockout A-549 Cell Line | EDJ-KQ61817 | Human | 2690 | Details Get a Quote |
| TRPV4 Knockout A-549 Cell Line | EDJ-KQ65471 | Human | 59341 | Details Get a Quote |
| GHR Knockout HCT 116 Cell Line | EDJ-KQ70304 | Human | 2690 | Details Get a Quote |
| TRPV4 Knockout HCT 116 Cell Line | EDJ-KQ73909 | Human | 59341 | Details Get a Quote |
Displaying Records 1 To 13 Of 13 Records
Frequently Asked Questions About cartilage development involved in endochondral bone morphogenesis
What is GO:0060351?
GO:0060351 is the Gene Ontology biological process term for cartilage development involved in endochondral bone morphogenesis, the progression of the cartilage template that provides a scaffold for endochondral bone mineralization.
What does cartilage development involved in endochondral bone morphogenesis mean?
It refers to the formation, growth, and maturation of the transient cartilage that is later replaced by bone during endochondral ossification.
What genes are involved in cartilage development involved in endochondral bone morphogenesis?
Key genes include SOX9, RUNX2, IHH, PTHLH, COL2A1, COL10A1, ACAN, MMP13, VEGFA, and FGFR3, among others [1,7,8].
Why is endochondral bone morphogenesis important?
It is the main mechanism for forming long bones, vertebrae, and the appendicular skeleton, and defects cause skeletal dysplasias and impaired fracture healing [1,3].
How is GO:0060351 different from endochondral ossification?
GO:0060351 focuses specifically on the cartilage progression step, whereas endochondral ossification broadly includes the subsequent bone formation and mineralization.
What cell types are involved in this process?
Mesenchymal progenitors, proliferating chondrocytes, hypertrophic chondrocytes, and vascular-associated skeletal progenitors are the main cell types [1,2].
What diseases are linked to defects in this process?
Skeletal dysplasias, metabolic bone disorders, and delayed fracture healing in aging or endocrine disease are linked to defects in this process [1,3,5].
How can CRISPR be used to study cartilage development involved in endochondral bone morphogenesis?
CRISPR knockout, point-mutation knock-in, tagged knock-in, and overexpression models can test the causal role of candidate genes in chondrocyte differentiation and matrix production [2,4].
What methods are used to study GO:0060351?
RNA-seq, histology, immunohistochemistry, proteomics, lineage tracing, reporter assays, and micro-CT are commonly used [2,6,7].
What is the role of RUNX2 in this process?
RUNX2 is a key transcription factor regulating chondrocyte and osteoblast maturation during endochondral bone development.
Conclusion
GO:0060351 provides a precise annotation for the cartilage progression that underpins endochondral bone formation, a process essential for vertebrate skeletal development and repair [1,2]. Its core regulators, including SOX9, RUNX2, and IHH, are well established, and its disruption is linked to skeletal dysplasias, metabolic bone disease, and impaired healing [1,3,5,8]. CRISPR-based models and modern profiling methods now make it feasible to dissect this process at scale and to translate findings into skeletal regenerative strategies [2,4].
References
- 1. Berendsen AD et al.. 2015. Bone development.. Bone 80:14-18 PMID: 26453494
- 2. Trompet D et al.. 2024. Skeletal stem and progenitor cells in bone development and repair.. J Bone Miner Res 39(6):633-654 PMID: 38696703
- 3. Saul D et al.. 2022. Fracture Healing in the Setting of Endocrine Diseases, Aging, and Cellular Senescence.. Endocr Rev 43(6):984-1002 PMID: 35182420
- 4. Shen Z et al.. 2025. An atlas of early human mandibular endochondral and osteogenic paracrine signaling regions of Meckel's cartilage.. Proc Natl Acad Sci U S A 122(12):e2420466122 PMID: 40096606
- 5. Serra-Vinardell J et al.. 2020. Bone development and remodeling in metabolic disorders.. J Inherit Metab Dis 43(1):133-144 PMID: 30942483
- 6. Nguyen JC et al.. 2024. The Immature Pediatric Appendicular Skeleton.. Semin Musculoskelet Radiol 28(4):361-374 PMID: 39074720
- 7. Reddi AH. 1994. Bone and cartilage differentiation.. Curr Opin Genet Dev 4(5):737-44 PMID: 7849513
- 8. Komori T. 2020. Molecular Mechanism of Runx2-Dependent Bone Development.. Mol Cells 43(2):168-175 PMID: 31896233
